The Increasing Metabolic Disorder and Circulatory Diseases to Foster the Growth of the Global Vasculitis Market

Published: Jul 2019

The global vasculitis market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2021-2027). The rising cases related to metabolic disorder and circulatory diseases such as peripheral artery disease is one of the prime factors affecting and driving the market. According to the American College of Cardiology across the globe, the incidence related to peripheral artery disease had been increasing at an increasing rate. In 2019, around 113 million cases were been observed of peripheral artery disease of which around 74,100 death occurred across the globe. This in turn is boosting the market for providing effective treatment to patients suffering from it in order to overcome diseases.

Browse the full report description of "Global Vasculitis Market Research By Type (Large Vessels, Medium Vessels and Small Vessels), By Diagnosis Tests (Blood Test, Urine Test, Imaging Test and Other), By Therapeutic Class (Corticosteroids, Immunosuppressants and Biologics) and By End Users (Hospitals and Clinics, Diagnosis Center, Research Institutes and Other) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/vasculitis-market

The demands of the vasculitis market are increasing its adoption of treatment and diagnosis through various testing across the globe. To gain on the opportunity key players operating in the global vasculitis market had been adopting strategies such as new launches. For instance, in March 2020, Novartis AG had introduced Beovu for the treatment of patients suffering from vasculitis.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Diagnosis Tests

o By Therapeutic Class

o By End Users

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- BRISTOL-MYERS SQUIBB CO., ChemoCentryx, Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Novartis AG

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Vasculitis Market

By Type

    • Large Vessels

    • Medium Vessels

    • Small Vessels

By Diagnosis Tests

    • Blood Test

    • Urine Test   

    • Imaging Test

    • Other

By Therapeutic Class

    • Corticosteroids

    • Immunosuppressants

    • Biologics

By End Users

    • Hospitals And Clinics

    • Diagnosis Center

    • Research Institutes

    • Other

Global Vasculitis Market by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/vasculitis-market